Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Serial Next-Generation Sequencing for Detection of Germline Predisposition in Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2024-205069

Published: 2024

Journal Articles

Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease

Dong Won Baek, Sr., Joon Ho Moon, Jae-Sook Ahn, Seong Kyu Park, Ik Chan Song, Ho-Sup Lee, Won Sik Lee, Jong Ho Won, Hong Ghi Lee, June-Won Cheong, Yeung-Chul Mun, Chul W. Jung, Je-Hwan Lee, Hyeoung-Joon Kim, Sang Kyun Sohn

Blood (2021) 138 (Supplement 1): 2889.

https://doi.org/10.1182/blood-2021-154470

Published: 2021

Journal Articles

The Predictors and Prevention of the Central Nervous System Relapse in Patients with Extranodal NK/T Cell Lymphoma, Nasal Type

Hyera Kim, Eo Jin Kim, Sang Eun Yoon, Youngil Koh, Dok Hyun Yoon, Seok Jin Kim, MD PhD, Sung-Soo Yoon, MD PhD, Hong Ghi Lee, Won Seog Kim, MD PhD

Blood (2019) 134 (Supplement_1): 2847.

https://doi.org/10.1182/blood-2019-128154

Published: 2019

Journal Articles

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Blood (2019) 134 (Supplement_1): 4035.

https://doi.org/10.1182/blood-2019-126637

Published: 2019

Journal Articles

Blinatumomab Treatment in Korean Adult Patients with Relapse/Refractory Acute Lymphoblastic Leukemia

Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Jae-Ho Yoon, MD PhD, Seok Lee, MD PhD, Dae Sik Kim, MD PhD, Se Ryun Lee, MD PhD, Sung-Hyun Kim, MD PhD, Ji Hyun Lee, MD PhD, Soo-Mee Bang, MD PhD, Youngil Koh, MD, Ho-Young Yhim, MD, Sang Kyun Sohn, MDPhD, Ik-Chan Song, MD, Hong-ghi Lee, MD PhD, June-Won Cheong, MDPhD, Yunsuk Choi, MD, Ho-Jin Shin, MD PhD

Blood (2017) 130 (Supplement 1): 5004.

https://doi.org/10.1182/blood.V130.Suppl_1.5004.5004

Published: 2017

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Blood (2016) 128 (22): 5432.

https://doi.org/10.1182/blood.V128.22.5432.5432

Published: 2016

Journal Articles

Similar Levels of Complement Activation in Both Patients with Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: The Report from the Korean TTP Registry

Blood (2014) 124 (21): 4195.

https://doi.org/10.1182/blood.V124.21.4195.4195

Published: 2014

Journal Articles

Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome.

Yun-Gyoo Lee, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, June-Won Cheong, MD, PhD, Yoo-Hong Min, MD, PhD, Soo-Mee Bang, MD, PhD, Chul Soo Kim, Yong Park, MD, Yeung Chul Mun, Jinny Park, Jae Hoon Lee, Hong Ghi Lee, Yeo-Kyeoung Kim, MD.PhD., Hyeoung-Joon Kim, MD, PhD

Blood (2012) 120 (21): 2843.

https://doi.org/10.1182/blood.V120.21.2843.2843

Published: 2012

Journal Articles

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

Blood (2012) 120 (21): 1691.

https://doi.org/10.1182/blood.V120.21.1691.1691

Published: 2012

Journal Articles

High Dose Etoposide Plus G-CSF As an Effective Mobilization Regimen in Patients with NHL Previously Treated with R-CHOP or CHOP Chemotherapy. Retrospective Multicenter Study

Shin Young Hyun, Yu Ri Kim, yun Deok Kim, Do Yoo Whang, Soo Jeong Kim, June-Won Cheong, Hong Ghi Lee, Deok-Hwan Yang, Jae Sook Ahn, MD, Won-Sik Lee, Ryu Hon Mo, Young-Rok Do, Ho Sup Lee, MD, Jae Hoon Lee, Sung Yong Oh, Cheolwon Suh, MD, Ho-Young Yhim, Jin Seok Kim

Blood (2012) 120 (21): 1917.

https://doi.org/10.1182/blood.V120.21.1917.1917

Published: 2012

Journal Articles

Clinical Features of Severe Acquired ADAMTS13 Deficiency in Thrombotic Thrombocytopenic Purpura: Second Report of the Korean TTP Registry.

Doyeun Oh, Moon Ju Jang, Inho Kim, MD, PhD, Soo-Mee Bang, MD, PhD, Chul-Won Jung, Jong-Wook Lee, Ki-Seong Eom, Hong Ghi Lee, Yeo-Kyeoung Kim, Byung Soo Kim, Jin-Seok Kim, Young Lee, Ho-Young Yhim, Sang Kyun Sohn, MD, Hwi-Joong Yoon, MD, PhD, Seongsoo Jang, Deog-Yeon Jo, MD, PhD, Goon Jae Cho

Blood (2012) 120 (21): 2188.

https://doi.org/10.1182/blood.V120.21.2188.2188

Published: 2012

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

Incidence and Biologic Features of 5q Deletion and 5q- Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008.

Hye Ryun Lee, Dae Sik Hong, Dae Young Zang, Hong Ghi Lee, Hwi-Joong Yoon, Hyeoung-Joon Kim, Inho Kim, Jae-Sook Ahn, Jong-Seok Lee, June-Won Cheong, Kyung-A Lee, Soo-Mee Bang, Su Yon Park, Yeo Min Yun, Yoo-Hong Min, You Kyung Lee, Dong Soon Lee, The Korean Society of Hematology AML/MDS Working Party

Blood (2009) 114 (22): 2778.

https://doi.org/10.1182/blood.V114.22.2778.2778

Published: 2009

NARROW

Serial Next-Generation Sequencing for Detection of Germline Predisposition in Acute Myeloid Leukemia

Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease

The Predictors and Prevention of the Central Nervous System Relapse in Patients with Extranodal NK/T Cell Lymphoma, Nasal Type

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Blinatumomab Treatment in Korean Adult Patients with Relapse/Refractory Acute Lymphoblastic Leukemia

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Similar Levels of Complement Activation in Both Patients with Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: The Report from the Korean TTP Registry

Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome.

Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or –intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party

High Dose Etoposide Plus G-CSF As an Effective Mobilization Regimen in Patients with NHL Previously Treated with R-CHOP or CHOP Chemotherapy. Retrospective Multicenter Study

Clinical Features of Severe Acquired ADAMTS13 Deficiency in Thrombotic Thrombocytopenic Purpura: Second Report of the Korean TTP Registry.

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Incidence and Biologic Features of 5q Deletion and 5q- Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only